Withdrawal: Makena
Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.
Recent Announcements
Clinical workflow changes through Epic®
Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.Oct. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Oct. 2026Important Notices
CME Webinar: Oral Care—An Important Infection Prevention Tool
Oral healthcare is a routine part of patient care, yet nurses and physicians may not always recognize the risks associated with inadequate oral care. Please join us for a live educational session on Tuesday, Dec. 8, that will help providers understand the importance of oral care and how appropriate practices can help reduce healthcare-associated infections, readmissions, and lengthy hospital stays.Oct. 2026Education/Webinars